DA 9701
Alternative Names: DA-9701; MotilitoneLatest Information Update: 28 Dec 2022
At a glance
- Originator Dong-A Pharmaceutical
- Developer Dong-A Pharmaceutical; Dong-A ST
- Class Laxatives; Phytotherapies
- Mechanism of Action Motilin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Dyspepsia
Highest Development Phases
- Marketed Non-ulcer dyspepsia
- No development reported Constipation
Most Recent Events
- 28 Dec 2022 Discontinued - Preclinical for Non-ulcer dyspepsia in China (PO)
- 28 Feb 2020 No recent reports of development identified for preclinical development in Non-ulcer-dyspepsia in China (PO)
- 28 Feb 2019 No recent reports of development identified for clinical-Phase-Unknown development in Constipation in South Korea (PO)